Comparison of efficacy of immune checkpoint inhibitors (ICIs) between younger and older patients: A systematic review and meta-analysis

•This meta-analysis compared the efficacy of ICIs between younger and older patients.•ICIs significantly improved OS in both younger (HR, 0.75) and older (HR, 0.73) groups.•An improvement in PFS was observed in younger (HR, 0.58) and older (HR, 0.77) patients.•In the PD-1 inhibitor subgroup, a signi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer treatment reviews Jg. 45; S. 30 - 37
Hauptverfasser:	Nishijima, Tomohiro F., Muss, Hyman B., Shachar, Shlomit S., Moschos, Stergios J.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Netherlands Elsevier Ltd 01.04.2016
Schlagworte:	Age Age Factors Aging - immunology Antibodies, Monoclonal - classification Antibodies, Monoclonal - immunology Antibodies, Monoclonal - pharmacology Antineoplastic Agents - classification Antineoplastic Agents - immunology Antineoplastic Agents - pharmacology Disease-Free Survival Hematology, Oncology and Palliative Medicine Humans Immune checkpoint inhibitor Immunosenescence Meta-analysis Neoplasms - drug therapy Neoplasms - immunology Overall survival Progression-free survival Randomized Controlled Trials as Topic Systematic review Treatment Outcome Immune checkpoint inhibitor Immunosenescence Systematic review Overall survival Progression-free survival Age Meta-analysis
ISSN:	0305-7372, 1532-1967, 1532-1967
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!